The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: F8 vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000132.4(F8):c.2840C>G (p.Pro947Arg)

CA10568278

1685797 (ClinVar)

Gene: F8
Condition: hemophilia A
Inheritance Mode: X-linked inheritance
UUID: 0fc2bdbc-0a64-452e-a356-311717e7520c
Approved on: 2025-05-02
Published on: 2025-05-02

HGVS expressions

NM_000132.4:c.2840C>G
NM_000132.4(F8):c.2840C>G (p.Pro947Arg)
NC_000023.11:g.154930950G>C
CM000685.2:g.154930950G>C
NC_000023.10:g.154159225G>C
CM000685.1:g.154159225G>C
NC_000023.9:g.153812419G>C
NG_011403.1:g.96774C>G
NG_011403.2:g.96774C>G
ENST00000360256.9:c.2840C>G
ENST00000647125.1:c.*2506C>G
ENST00000360256.8:c.2840C>G
NM_000132.3:c.2840C>G
More

Likely Benign

Met criteria codes 2
PS3 BA1
Not Met criteria codes 2
BP4 PP3

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Coagulation Factor Deficiency Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for F8 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Coagulation Factor Deficiency VCEP
The c.2840C>G variant in F8 is a missense variant predicted to cause substitution of Proline by Arginine at amino acid 947 (p.Pro947Arg). In gnomAD v2.1.1, the Grpmax total for exomes is 0.0003539 and for genomes is 0.0003564, which are both higher than the ClinGen Coagulation Factor Deficiency VCEP threshold (>0.000333) for BA1. In gnomAD v3.1.2, the Grpmax total for genomes is 0.0007292, which is also above the cut off to apply BA1. An one stage clotting assay in HEK293T cells showed reduced FVIII:C of about 30% indicating that this variant impacts protein function (PMID: 24108539)(PS3). The computational predictor REVEL gives a score of 0.578, which is neither above nor below the thresholds predicting a damaging (>=0.6) or benign impact (<=0.3) on F8 function. this variant is classified as a likely benign for Hemophilia A based on the ACMG/AMP criteria applied, as specified by the ClinGen Coagulation Factor Deficiency Variant Curation Expert Panel for F8 (version 1.0.0, released 10/5/2023): BA1, PS3.
Met criteria codes
PS3
1 stage clotting assay in HEK293T cells showed reduced FVIII:C of about 30% (cutoff <40%) indicating that this variant impacts protein function (PMID: 24108539)(PS3).

BA1
The highest population minor allele frequency in gnomAD v2.1.1 is 0.0007724 (11/14242 alleles) in the East Asian population with grpmax for genomes = 0.0003539 and grpmax for exomes = 0.0003564, which is higher than the ClinGen Coagulation Factor Deficiency VCEP threshold (>0.000333) for BA1, and therefore meets this criterion (BA1). The highest MAF in gnomAD v4.1.0 is 0.0004754 (16/33657 alleles) in the East Asian population.
Not Met criteria codes
BP4
The computational predictor REVEL gives a score of 0.578, which is neither above nor below the thresholds predicting a damaging (>=0.6) or benign impact (<=0.3) on F8 function.
PP3
The computational predictor REVEL gives a score of 0.578, which is neither above nor below the thresholds predicting a damaging (>=0.6) or benign impact (<=0.3) on F8 function.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.